These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33375918)

  • 21. A spraying applicator device is not required for efficacy of a live intranasal respiratory vaccine in young calves, which improves user convenience.
    Nuijten P; van der Loop J; van Rooij M; Makoschey B; Vertenten G
    Vet Immunol Immunopathol; 2020 Dec; 230():110130. PubMed ID: 33068827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technical Note: Using enzyme-linked immunosorbent assays to evaluate humoral responses to vaccination against respiratory viruses in beef cattle.
    Cooke RF; Paiva R; Pohler KG
    J Anim Sci; 2020 Aug; 98(8):. PubMed ID: 32761238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formalin-inactivated bovine RSV vaccine influences antibody levels in bronchoalveolar lavage fluid and disease outcome in experimentally infected calves.
    Kalina WV; Woolums AR; Gershwin LJ
    Vaccine; 2005 Aug; 23(37):4625-30. PubMed ID: 15967545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1.
    DesCôteaux L; Cécyre D; Elsener J; Beauchamp G
    Can Vet J; 2003 Oct; 44(10):816-21. PubMed ID: 14601677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
    Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
    Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
    Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H
    J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vaccination of pregnant beef heifers on the concentrations of serum IgG and specific antibodies to bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 in heifers and calves.
    Reppert EJ; Chamorro MF; Robinson L; Cernicchiaro N; Wick J; Weaber RL; Haines DM
    Can J Vet Res; 2019 Oct; 83(4):313-316. PubMed ID: 31571732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
    Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
    Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of a modified-live combination vaccine against respiratory and reproductive diseases in pregnant cows.
    Ellsworth MA; Brown MJ; Fergen BJ; Ficken MD; Tucker CM; Bierman P; TerHune TN
    Vet Ther; 2003; 4(2):120-7. PubMed ID: 14506587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of neonatal vaccination for bovine respiratory disease in the face of a dual challenge with bovine viral diarrhea virus and Mannheimia hemolytica.
    Perkins-Oines S; Dias N; Krafsur G; Abdelsalam K; Perry G; Ensley D; Jones C; Chase CCL
    Vaccine; 2023 May; 41(19):3080-3091. PubMed ID: 37045678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of interferon and bovine herpesvirus-1-specific IgA levels in nasal secretions of dairy cattle administered an intranasal modified live viral vaccine prior to calving or on the day of calving.
    Cortese VS; Woolums A; Hurley DJ; Berghaus R; Bernard JK; Short TH
    Vet Immunol Immunopathol; 2017 May; 187():35-41. PubMed ID: 28494927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves.
    Ellis JA; Gow SP; Mahan S; Leyh R
    J Am Vet Med Assoc; 2013 Dec; 243(11):1602-8. PubMed ID: 24261811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
    Xue W; Mattick D; Smith L
    Vaccine; 2011 Jun; 29(29-30):4657-62. PubMed ID: 21596076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence to bovine virus diarrhoea virus and other viruses of the bovine respiratory complex in Venezuela (Apure State).
    Obando RC; Hidalgo M; Merza M; Montoya A; Klingeborn B; Moreno-López J
    Prev Vet Med; 1999 Aug; 41(4):271-8. PubMed ID: 10530426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a quadrivalent vaccine against respiratory virus on the incidence of respiratory disease in weaned beef calves.
    Stilwell G; Matos M; Carolino N; Lima MS
    Prev Vet Med; 2008 Jul; 85(3-4):151-7. PubMed ID: 18378342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
    Williams LBA; Fry LM; Herndon DR; Franceschi V; Schneider DA; Donofrio G; Knowles DP
    PLoS One; 2019; 14(4):e0215605. PubMed ID: 31002724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of calf age and administration route of initial multivalent modified-live virus vaccine on humoral and cell-mediated immune responses following subsequent administration of a booster vaccination at weaning in beef calves.
    Woolums AR; Berghaus RD; Berghaus LJ; Ellis RW; Pence ME; Saliki JT; Hurley KA; Galland KL; Burdett WW; Nordstrom ST; Hurley DJ
    Am J Vet Res; 2013 Feb; 74(2):343-54. PubMed ID: 23363363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine.
    Kerkhofs P; Renjifo X; Toussaint JF; Letellier C; Vanopdenbosch E; Wellemans G
    Vet Rec; 2003 May; 152(22):681-6. PubMed ID: 12803395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunology of the bovine respiratory disease complex.
    Ellis JA
    Vet Clin North Am Food Anim Pract; 2001 Nov; 17(3):535-50, vi-vii. PubMed ID: 11692507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of single vaccination versus revaccination with a modified-live virus vaccine containing bovine herpesvirus-1, bovine viral diarrhea virus (types 1a and 2a), parainfluenza type 3 virus, and bovine respiratory syncytial virus in the prevention of bovine respiratory disease in cattle.
    Step DL; Krehbiel CR; Burciaga-Robles LO; Holland BP; Fulton RW; Confer AW; Bechtol DT; Brister DL; Hutcheson JP; Newcomb HL
    J Am Vet Med Assoc; 2009 Sep; 235(5):580-7. PubMed ID: 19719452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.